Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diclofenac (ausschließlich GEL 25 mg), ATC D11AX18 für die Zeit 01.04.2025 - 31.03.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diclofenac (ausschließlich GEL 25 mg), ATC D11AX18 für die…”. Bids close on 5 February 2027. To qualify, bidders need at least one similar completed work.
The work
Conclusion of a non-exclusive discount agreement for the active substance Diclofenac (exclusively GEL 25 mg), ATC D11AX18, for the period 01.04.2025 - 31.03.2027.
- Agreement is for Diclofenac (exclusively GEL 25 mg), ATC D11AX18
- Contract period is 01.04.2025 to 31.03.2027
Key facts
- Contract period
- 01.04.2025 - 31.03.2027
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The tender is for a discount agreement, not a standard procurement of goods or services, which may affect the applicability of standard procurement rules.
- The document states the procedure is not in the scope of cartel procurement law, but also mentions a formal procurement procedure under the GWB.
- The tender is published using a form for open procedures, despite the author's assertion that it is not one.
Experience
- At least 1 similar work — Experience with pharmaceutical discount agreements for Diclofenac (GEL 25 mg).
Certifications and registrations
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenSubmission via email to openhouse@dak.de.
- Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission via email to openhouse@dak.de.
- Anlage 1 zum VertragSubmission via email to openhouse@dak.de.
- Anlage 2 zum VertragSubmission as an Excel file via email to openhouse@dak.de.
- Eigenerklärung des Unternehmens, dass keines der Ausschlusskriterien gemäß §§ 123 und 124 GWB vorliegtIncluded with the offer letter.